Showing results (91-100 of 26,308) with videos related to
Sort By:
Pageof 2,631
Bioorganic & Medicinal Chemistry Letters|August 25, 2015
Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M₁ agonistsBin Liu, Carrie H Croy, Stephen A Hitchcock, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2016
Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agentsR Naresh Kumar, G Jitender Dev, N Ravikumar, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2016
Piperidinyl thiazole isoxazolines: A new series of highly potent, slowly reversible FAAH inhibitors with analgesic propertiesStephen O Pember, Galo L Mejia, Theodore J Price, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2016
Design, synthesis and evaluation of pyrrolo[2,3-d]pyrimidine-phenylamide hybrids as potent Janus kinase 2 inhibitorsTingfang Wang, Xiaofei Liu, Meixi Hao, et al.Bioorganic & Medicinal Chemistry Letters|April 28, 2016
Design, synthesis and biological evaluation of potent FAAH inhibitorsWei Tuo, Natascha Leleu-Chavain, Amélie Barczyk, et al.Bioorganic & Medicinal Chemistry Letters|April 28, 2016
Comparison of small molecules and oligonucleotides that target a toxic, non-coding RNAMatthew G Costales, Suzanne G Rzuczek, Matthew D DisneyBioorganic & Medicinal Chemistry Letters|April 28, 2016
The alkyl linkers in tandem-homodimers of a β-sheet-forming nonapeptide affect the self-assembled nanostructuresKin-Ya Tomizaki, Atsushi Tanaka, Hiroki Shimada, et al.Bioorganic & Medicinal Chemistry Letters|April 28, 2016
Design, synthesis and biological evaluation of pyrazolylaminoquinazoline derivatives as highly potent pan-fibroblast growth factor receptor inhibitorsJun Fan, Yang Dai, Jingwei Shao, et al.Bioorganic & Medicinal Chemistry Letters|April 28, 2016
Effective molarity in a nucleic acid-controlled reactionMichael J Catalano, Nathan E Price, Kent S GatesBioorganic & Medicinal Chemistry Letters|April 28, 2016
The discovery and the structural basis of an imidazo[4,5-b]pyridine-based p21-activated kinase 4 inhibitorJeung Kuk Park, Sunmin Kim, Yu Jin Han, et al.Pageof 2,631